-
FITC-Concanavalin A (ConA) Workflow Guide
2026-09-08
FITC-Concanavalin A (ConA) Conjugate is a direct fluorescent lectin reagent for detecting accessible α-D-glucose and α-D-mannose moieties in cell, tissue, and other glycan-containing samples. It is suited to immunofluorescence staining and flow cytometry carbohydrate-probe workflows, but not to non-carbohydrate targets or assays performed outside the specified storage and handling conditions.
-
Thapsigargin B6614 for Reliable Cell Assays
2026-09-07
A scenario-driven guide to using Thapsigargin (SKU B6614) for calcium signaling, apoptosis, viability, and endoplasmic reticulum stress experiments. It connects reported potency, formulation, storage, and assay-design considerations to practical laboratory decisions.
-
Protease Inhibitor Cocktail for METTL3 Assays
2026-09-05
Protect METTL3, HSP90, ubiquitinated proteins, and other labile targets during lysis with a broad-spectrum inhibitor system that also addresses metalloproteases. Its separately supplied EDTA component enables flexible use in Western blotting and co-immunoprecipitation while highlighting compatibility checks for IMAC and metal-dependent kinase assays.
-
GPR107 Deficiency Promotes Diabetic Nephropathy
2026-09-05
Xu et al. identify GPR107 as a regulator of podocyte collagen type IV homeostasis and show that its deficiency aggravates diabetic nephropathy through impaired AT1R internalization and enhanced Ca2+/CREB signaling. The study links membrane trafficking to glomerular basement membrane remodeling, providing a mechanistic framework for future renal cell signaling research.
-
Exendin-4: From GLP-1 Signaling to Assay Design
2026-09-04
Exendin-4, also known as Exenatide in therapeutic research contexts, is a powerful GLP-1 receptor agonist for dissecting cAMP signaling, beta cell activity, and metabolic phenotypes. This guide connects the peptide’s molecular pharmacology with practical assay decisions and interprets recent yeast-expression research without conflating production feasibility with biological validation.
-
XAV-939: Tankyrase Control of Wnt Signaling
2026-09-04
XAV-939, also called NVP-XAV939, is a cell-permeable TNKS1/TNKS2 inhibitor that stabilizes axin and suppresses Wnt/β-catenin signaling. Its validated research uses include cancer research, fibrotic disease research, osteogenic differentiation, and defined-factor cardiac reprogramming studies.
-
URB597: Designing Better Endocannabinoid Assays
2026-09-03
URB597 and KDS-4103 provide a selective way to interrogate FAAH–anandamide biology without directly stimulating cannabinoid receptors. This article presents an assay-centered framework linking biochemical target engagement to pain, affective, neuroplasticity, and neuroinflammation readouts.
-
Tetrazolium (chloride) for Reliable Viability Assays
2026-09-02
Learn how Tetrazolium (chloride), SKU C5688, supports reproducible mitochondrial dehydrogenase, cell viability, and ischemic tissue assays. This scenario-based guide explains assay interpretation, protocol parameters, tissue compatibility, and practical supplier-selection criteria.
-
Carbon Nanotube–Zinc Sponge for Diabetic Wounds
2026-09-02
This 2025 Materials Today Bio study reports a multifunctional carbon nanotube and pyrrolidonecarboxylic acid zinc sponge designed to coordinate hemostasis, antibacterial activity, inflammation control, and tissue repair in diabetic wounds. Its combination of photothermal conversion, exudate absorption, gradual Zn2+ release, and endogenous electric-field coupling offers a systems-level strategy, although further work is needed to define material safety, treatment dosing, and clinical transferability.
-
Dual-Action Inhibition of p38α MAP Kinase
2026-09-01
A 2024 bioRxiv preprint identifies a mechanism in which selected kinase inhibitors both inhibit p38α MAP kinase activity and accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Structural and biochemical results suggest that inhibitor-induced activation-loop conformations can expose phospho-threonine, offering a potential route to more durable and specific kinase pathway control.
-
BODIPY 581/591 C11 for Lipid Peroxidation
2026-09-01
BODIPY 581/591 C11 converts membrane oxidation into a quantitative red-to-green fluorescence ratio, making it useful for live-cell oxidative stress measurement and treatment-response studies. This workflow shows how to apply the probe to cardiomyocyte injury, nanozyme evaluation, ferroptosis research, and antioxidant capacity evaluation while avoiding common interpretation errors.
-
GANT61: Selective GLI Inhibitor Guide
2026-08-31
GANT61 is a GLI inhibitor that suppresses GLI1/GLI2-mediated transcription and supports Hedgehog pathway research. Product data report an approximately 5 μM transcriptional IC50 and tumor growth suppression in selected xenograft models, while recent bladder cancer research provides a separate GLI2–PRDX1 ferroptosis rationale.
-
Galectin-1–FIP200 Axis in Hepatic Steatosis
2026-08-30
A 2026 study identifies galectin-1 as an upstream suppressor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through interaction with the FIP200 autophagy scaffold. The work connects a defined protein interface to metabolic dysfunction and provides a mechanistic framework for combining autophagy, lipid, and glucose-uptake measurements in future NAFLD studies.
-
MVC Activates RhoA/ROCK1 to Open Tight Junctions
2026-08-29
The reference study identifies a previously unrecognized entry mechanism in which MVC VP2 interacts with ROCK1 and activates the RhoA/ROCK1/MLC2 axis, weakening epithelial tight junctions and exposing Occludin. Its inhibitor-rescue experiments connect cytoskeletal remodeling with viral infection and nominate host-cell signaling as a potential target for anti-MVC research.
-
Degarelix Acetate: From Mechanism to Assay Design
2026-08-29
Degarelix acetate is a selective GnRH receptor antagonist with value far beyond routine hormone suppression experiments. This guide connects receptor pharmacology, assay architecture, stable-isotope analysis, and prostate cancer research to improve interpretation and reproducibility.